The New York Genome Center (NYGC) is dedicated to advancing biomedical research and clinical care with the goal of improving patient outcomes and saving lives. As a collaborative consortium comprising leading academic, medical, and industry experts, NYGC focuses on translating genomic research into practical clinical solutions for serious diseases. The organization operates non-profit genome research facilities that empower researchers to conduct advanced genomic studies and integrate their findings with cutting-edge technologies and the expertise of physician-scientists. This unique approach fosters innovation and enhances the ability to address complex health challenges effectively and ethically.
Co-Founder, CEO, Scientific Director and Board Member
1 past transactions
Gencove
Seed Round in 2017
Gencove is a software platform that focuses on high-throughput and cost-effective genome sequencing through the use of low-pass sequencing technology. The company aims to revolutionize genomics research and diagnostics across various species by providing fast and affordable whole-genome sequencing solutions. Gencove develops both molecular and computational tools that facilitate low-cost genome sequencing, making genomic data accessible to researchers in diverse industries, including agriculture and pharmaceuticals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.